| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2020-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2aa61e6f0fe7725a60799d001c624b19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfa4328791e884e7b3cbf48881375b14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa12507475c902dce6ed692fcf392c62 |
| publicationDate |
2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220119065-A |
| titleOfInvention |
Uses of Lemborexant for the Treatment of Insomnia |
| abstract |
A method for treating insomnia, wherein a dosage form comprising lemborexant or a pharmaceutically acceptable salt thereof is administered to a patient in need thereof in a single daily dose ranging from 5 mg to 10 mg of lemborexant or a medicament thereof. Oral administration of an equivalent dose of a scientifically acceptable salt, provided that the maximum dose is 1 if the patient has moderate liver injury classified as Child-Pugh Class B under the Child-Pugh Classification A method is disclosed, wherein the method is 5 mg once daily of lemborexant or an equivalent dose of a pharmaceutically acceptable salt thereof. |
| priorityDate |
2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |